SCHEMBL2986458

SCHEMBL2986458

Oc1ccccc1-c1nc2ccccn2c1NC1CCCC1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.70
SALL4 Q9UJQ4 2/20 0.65
ALDH1A1 P00352 5/20 0.63
GAA P10253 4/20 0.63
MAPT P10636 3/20 0.63
MAPK1 P28482 2/20 0.63
NPSR1 Q6W5P4 1/20 0.63
L3MBTL1 Q9Y468 1/20 0.63
ADORA1 P30542 1/20 0.62
KDM4E B2RXH2 4/20 0.61
GFER P55789 2/20 0.61
TRIM33 Q9UPN9 3/20 0.57
TRIM24 O15164 2/20 0.57
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
HTT P42858 2/20 0.54
ROCK2 O75116 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1965729 0.99 ALOX5 (0.72) ALOX5SALL4ALDH1A1GAAMAPT
SCHEMBL2611922 0.88 SALL4 (0.64) ALOX5SALL4ALDH1A1GAAMAPT
SCHEMBL2611941 0.86 ADORA1 (0.71) ALOX5SALL4ALDH1A1GAAMAPT
SCHEMBL20889569 0.86 SALL4 (0.67) ALOX5SALL4ALDH1A1GAAMAPT
SCHEMBL1965009 0.85 ALDH1A1 (0.63) ALOX5SALL4ALDH1A1GAAMAPT
SCHEMBL15172138 0.85 ADORA1 (0.69) ALOX5SALL4ALDH1A1GAAMAPT
SCHEMBL1970474 0.85 ALDH1A1 (0.63) ALOX5SALL4ALDH1A1GAAMAPT
SCHEMBL1966948 0.85 ALDH1A1 (0.63) ALOX5SALL4ALDH1A1GAAMAPT
SCHEMBL13464367 0.85 ALDH1A1 (0.63) ALOX5SALL4ALDH1A1GAAMAPT
SCHEMBL2984312 0.85 ALOX5 (0.70) ALOX5SALL4ALDH1A1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100173930-A1 Certain Chemical Entities, Compositions and Methods CYTOKINETICS, INC. 2010-07-08 US claimed
WO-2008016648-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS CYTOKINETICS, INCORPORATED (US) 2008-02-07 WO claimed
US-20100173930-A1 Certain Chemical Entities, Compositions and Methods CYTOKINETICS, INC. 2010-07-08 US disclosed
WO-2008016648-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS CYTOKINETICS, INCORPORATED (US) 2008-02-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100173930-A1 Certain Chemical Entities, Compositions and Methods TNNC1, TNNI3, TNNT2 ALOX5 3248/4885SALL4 4045/4885ALDH1A1 3165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.